Burning Rock Biotech
16 hedge funds and large institutions have $34.9M invested in Burning Rock Biotech in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
181% more capital invested
Capital invested by funds: $12.4M → $34.9M (+$22.5M)
3.09% more ownership
Funds ownership: 15.84% → 18.93% (+3.1%)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
+$3.94M |
| 2 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
+$292K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$159K |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$93.8K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$27.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$152K |
| 2 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
-$87K |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$44.3K |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$44.3K |
| 5 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
-$25.9K |
BNR Hedge Fund Activity: Q4 2025 in Review
16 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2025, worth a combined $34.9M — up 181% from $12.4M a quarter earlier.
Fund positioning in BNR was balanced in Q4 2025: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was CRCM LP, adding an estimated $3.94M. The largest seller was Morgan Stanley, cutting an estimated $152K.
- 16 institutional investors held Burning Rock Biotech (BNR) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $34.9M of Burning Rock Biotech stock for Q4 2025, up 181% quarter-over-quarter.
- 3 funds opened new Burning Rock Biotech positions in Q4 2025 and 3 closed out, a net change of 0 holders.
- The largest Burning Rock Biotech buyer in Q4 2025 was CRCM LP, an estimated $3.94M added.
- The largest Burning Rock Biotech seller in Q4 2025 was Morgan Stanley, an estimated $152K sold.
Based on aggregated 13F filings for Q4 2025.